Data spanning the past 90 days through February 07, 2026 reveals that Syndax Pharmaceuticals's three principal insider shareholders consist of Chief Executive Officer Michael A Metzger (508.85K shares), Director Dennis Podlesak (239.76K shares), Chief Financial Officer Keith A. Goldan (143.84K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Michael A Metzger | Chief Executive Officer | 508,849 | 06 Feb, 2026 |
| Dennis Podlesak | 239,763 | 06 Feb, 2026 | |
| Keith A. Goldan | Chief Financial Officer | 143,839 | 06 Feb, 2026 |
| Keith Katkin | 124,000 | 06 Feb, 2026 | |
| Pierre Legault | 114,000 | 06 Feb, 2026 | |
| Jennifer Jarrett | 114,000 | 06 Feb, 2026 | |
| Martin H. Jr. Huber | 103,000 | 06 Feb, 2026 | |
| Nicholas A.J. Botwood | Head Of R&D And Cmo | 95,165 | 06 Feb, 2026 |
| William Meury | 90,000 | 07 Feb, 2025 | |
| Neil Gallagher | President And Head Of R&D | 85,095 | 12 Feb, 2025 |
| Aleksandra Rizo | 49,000 | 06 Feb, 2026 | |
| Briggs Morrison | 34,836 | 09 Feb, 2024 | |
| Fabrice Egros | 32,000 | 03 Feb, 2022 | |
| Michael L. Meyers | Svp And Chief Medical Officer | 23,280 | 03 Feb, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Feb, 2026 | Keith A. Goldan | Common Stock | D | 2,082 | $20.62 | 143,839 | D | S |
| 06 Feb, 2026 | Michael A Metzger | Common Stock | D | 7,412 | $20.62 | 508,849 | D | S |
| 04 Feb, 2026 | Dennis Podlesak | Common Stock | A | 48,000 | $0.00 | 239,763 | D | A |
| 04 Feb, 2026 | Keith Katkin | Common Stock | A | 24,000 | $0.00 | 124,000 | D | A |
| 04 Feb, 2026 | Pierre Legault | Common Stock | A | 24,000 | $0.00 | 114,000 | D | A |
| 04 Feb, 2026 | Keith A. Goldan | Common Stock | A | 30,750 | $0.00 | 145,921 | D | A |
| 04 Feb, 2026 | Keith A. Goldan | Common Stock | A | 21,500 | $0.00 | 115,171 | D | A |
| 04 Feb, 2026 | Michael A Metzger | Common Stock | A | 144,600 | $0.00 | 516,261 | D | A |
| 04 Feb, 2026 | Michael A Metzger | Common Stock | A | 73,000 | $0.00 | 371,661 | D | A |
| 04 Feb, 2026 | Martin H. Jr. Huber | Common Stock | A | 24,000 | $0.00 | 103,000 | D | A |
| 04 Feb, 2026 | Jennifer Jarrett | Common Stock | A | 24,000 | $0.00 | 114,000 | D | A |
| 04 Feb, 2026 | Aleksandra Rizo | Common Stock | A | 24,000 | $0.00 | 49,000 | D | A |
| 04 Feb, 2026 | Nicholas A.J. Botwood | Common Stock | A | 36,000 | $0.00 | 95,165 | D | A |
| 04 Feb, 2026 | Nicholas A.J. Botwood | Common Stock | A | 24,000 | $0.00 | 59,165 | D | A |
| 30 Jan, 2026 | Keith A. Goldan | Common Stock | A | 1,219 | $8.48 | 93,671 | D | J |
| 01 Dec, 2025 | Keith A. Goldan | Common Stock | D | 1,224 | $0.00 | 92,452 | D | G |
| 08 Sep, 2025 | Michael A Metzger | Common Stock | A | 157,307 | $10.90 | 455,968 | D | M |
| 08 Sep, 2025 | Michael A Metzger | - | - | 298,661 | D | |||
| 08 Sep, 2025 | Michael A Metzger | Common Stock | D | 157,307 | $16.41 | 298,661 | D | S |
| 18 Aug, 2025 | Dennis Podlesak | Common Stock | D | 19,200 | $15.84 | 191,763 | D | S |